Twist Bioscience [TWST] vs Revvity [RVTY] Detailed Stock Comparison

Twist Bioscience Corporation

NASDAQ
Loading...

Revvity Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Twist Bioscience Corporation wins in 2 metrics, Revvity Inc. wins in 17 metrics, with 0 ties. Revvity Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Twist Bioscience Corporation Revvity Inc. Better
P/E Ratio (TTM) -45.26 45.77 Revvity Inc.
Price-to-Book Ratio 8.49 1.46 Revvity Inc.
Debt-to-Equity Ratio 24.79 46.87 Twist Bioscience Corporation
PEG Ratio 8.00 3.92 Revvity Inc.
EV/EBITDA -33.62 15.48 Revvity Inc.
Profit Margin (TTM) -19.56% 8.45% Revvity Inc.
Operating Margin (TTM) -31.73% 20.07% Revvity Inc.
EBITDA Margin (TTM) N/A 20.07% N/A
Return on Equity -16.79% 3.22% Revvity Inc.
Return on Assets (TTM) -13.49% 2.22% Revvity Inc.
Free Cash Flow (TTM) $-75.63M $509.41M Revvity Inc.
Dividend Yield N/A 0.25% N/A
1-Year Return 127.24% 6.55% Twist Bioscience Corporation
Price-to-Sales Ratio (TTM) 9.90 3.69 Revvity Inc.
Enterprise Value $3.79B $13.02B Revvity Inc.
EV/Revenue Ratio 9.68 4.56 Revvity Inc.
Gross Profit Margin (TTM) 52.05% 54.62% Revvity Inc.
Revenue per Share (TTM) $7 $25 Revvity Inc.
Earnings per Share (Diluted) $-1.27 $2.06 Revvity Inc.
Beta (Stock Volatility) 2.21 1.13 Revvity Inc.
Short % of Float 29.74% 11.04% Revvity Inc.

Twist Bioscience Corporation vs Revvity Inc. Stock Performance Analysis

Loading Price Chart...

TWST
RVTY

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Twist Bioscience Corporation6.07%15.35%64.31%79.49%160.03%149.43%
Revvity Inc.0.89%0.25%7.00%16.27%1.48%2.45%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Twist Bioscience Corporation127.24%316.00%-31.53%444.07%444.07%444.07%
Revvity Inc.6.55%-16.43%-33.86%90.37%284.64%376.61%

Performance & Financial Health Analysis: Twist Bioscience Corporation vs Revvity Inc.

MetricTWSTRVTY
Market Information
Market Cap i$3.61B$9.74B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i1,422,184860,236
90 Day Avg. Volume i1,214,561959,002
Last Close$80.79$100.55
52 Week Range$23.30 - $82.99$81.22 - $118.30
% from 52W High-2.65%-15.00%
All-Time High$214.07 (Jan 18, 2021)$203.16 (Dec 27, 2021)
% from All-Time High-62.26%-50.51%
Growth Metrics
Quarterly Revenue Growth0.17%0.06%
Quarterly Earnings Growth0.17%0.04%
Financial Health
Profit Margin (TTM) i-0.20%0.08%
Operating Margin (TTM) i-0.32%0.20%
Return on Equity (TTM) i-0.17%0.03%
Debt to Equity (MRQ) i24.7946.87
Cash & Liquidity
Book Value per Share (MRQ)$7.44$64.57
Cash per Share (MRQ)$3.23$8.23
Operating Cash Flow (TTM) i$-51,014,000$582.93M
Levered Free Cash Flow (TTM) i$-47,241,876$523.28M
Dividends
Last 12-Month Dividend Yield iN/A0.25%
Last 12-Month Dividend iN/A$0.28

Valuation & Enterprise Metrics Analysis: Twist Bioscience Corporation vs Revvity Inc.

MetricTWST (Apr 24, 2026)RVTY (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-45.2645.77
Forward P/E i-33.5315.70
PEG Ratio i8.003.92
Price to Sales (TTM) i9.903.69
Price to Book (MRQ) i8.491.46
Market Capitalization
Market Capitalization i$3.61B$9.74B
Enterprise Value i$3.79B$13.02B
Enterprise Value Metrics
Enterprise to Revenue i9.684.56
Enterprise to EBITDA i-33.6215.48
Risk & Other Metrics
Beta i2.211.13
Book Value per Share (MRQ) i$7.44$64.57

Financial Statements Comparison: Twist Bioscience Corporation vs Revvity Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTWST (2025)RVTY (2025)
Revenue/Sales i376.57M2.86B
Cost of Goods Sold i185.57M1.29B
COGS % of Revenue i49.3%45.2%
Gross Profit i191.00M1.56B
Gross Margin i50.7%54.8%
Research & Development i80.29M215.84M
Operating Income (EBIT) i-136.26M356.64M
Operating Margin i-36.2%12.5%
EBITDA i-160.25M792.21M
EBITDA Margin i-42.6%27.7%
Pre-Tax Income i-76.95M268.28M
Pre-Tax Income % of Revenue i-20.4%9.4%
Income Tax i719,00028.39M
Income Tax % of Revenue i0.2%1.0%
Net Income (Profit) i-77.67M241.20M
Profit Margin i-20.6%8.4%

Balance Sheet & Liquidity Metrics

MetricTWST (2025)RVTY (2025)
Cash & Equivalents i183.05M919.86M
Total Current Assets i332.97M2.24B
Total Current Assets % of Revenue i88.4%78.4%
Total Current Liabilities i91.41M1.33B
Total Current Liabilities % of Revenue i24.3%46.6%
Long-Term Debt i61.75M2.78B
Long-Term Debt % of Revenue i16.4%97.3%
Total Shareholders Equity i472.96M7.25B
Retained Earnings i-1.32B6.05B
Retained Earnings % of Revenue i-350.4%212.0%
Property, Plant & Equipment i150.96M165.44M

Cash Flow Statement Comparison

MetricTWST (2025)RVTY (2025)
Operating Cash Flow i1.59M586.69M
Operating Cash Flow % of Revenue i0.4%20.5%
Capital Expenditures i-28.00MN/A
Free Cash Flow i-75.63M509.41M
FCF Margin i-20.1%17.8%
Debt Repayment iN/A-521,000
Common Stock Repurchase i-16,000-820.82M

Short Interest & Institutional Ownership Analysis

MetricTWSTRVTY
Shares Short i14.15M8.24M
Short Ratio i13.077.79
Short % of Float i29.74%11.04%
Shares Outstanding i61.27M112.28M
Float Shares i54.55M102.65M
% Held by Insiders i1.50%0.34%
% Held by Institutions i122.49%103.68%
% Held by Public i-23.99%-4.02%

Dividend Analysis & Yield Comparison: Twist Bioscience Corporation vs Revvity Inc.

MetricTWSTRVTY
Last 12-Month Dividend iN/A$0.28
Last 12-Month Dividend Yield iN/A0.25%
3-Year Avg Annual Dividend iN/A$0.28
3-Year Avg Dividend Yield iN/A0.06%
3-Year Total Dividends iN/A$0.84
Ex-Dividend DateN/AJan 16, 2026